We found eighteen studies investigated in 208 GBM, 15 cell lines or GBM-derived stem cell cultures, and 5 animal models, several therapeutic approaches concerning HIF-1α/VEGF (Table 6, Fig. 2). This evidence concerns the gene VEGFA and glioblastoma.